Our main focus is the production of children's vaccines which are included in the National Immunisation Program of the Russian Federation.
Other key areas of the “Nanolek” product portfolio include in-house medicines designed for the treatment of oncological, autoimmune and orphan diseases.
Vaccines
Cegardex®
Human Papillomavirus Vaccine [Types 6, 11, 16, 18], Quadrivalent (Recombinant, Adsorbed)
Learn more
MenQuadfi®
Meningococcal Conjugate Vaccine Against Serogroups A, C, W, Y (Polysaccharide, Conjugated)
Learn more
Menactra®
Meningococcal Conjugate Vaccine Against N. meningitidis Serogroups A, C, W, Y (Polysaccharide, Conjugated)
Learn more
Pentaxim®
Adsorbed Diphtheria and Tetanus Vaccine, Acellular Pertussis Vaccine, Inactivated Poliomyelitis Vaccine, and Haemophilus influenzae type b Conjugate Vaccine
Learn more
PoliovakSin®
Purified, concentrated, inactivated liquid poliomyelitis vaccine of Sabin attenuated strains
Learn more
Oncology
Brukinza®
Antitumor drug, selective low-molecular-weight inhibitor of Bruton tyrosine kinase (BTK)
Learn more
Orphan
Hunterase®
Idursulfase beta — enzyme preparation for the treatment of metabolic disorders
Learn more
AGREEMENT ON OBTAINING INFORMATION ON PRESCRIPTION DRUGS
Attention! You are about to enter a section containing information about prescription drugs. This information is intended only for current medical and pharmaceutical professionals.
Please confirm that you are a current medical or pharmaceutical professional. If you are not a current medical or pharmaceutical professional, please do not proceed.
Are you a current medical or pharmaceutical professional?